FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387078052> ?p ?o ?g. }

• W4387078052 abstract "Abstract Emerging evidence suggests that the presence of tertiary lymphoid structures (TLS) and neutrophil–lymphocyte ratio (NLR) in peripheral blood is associated with the treatment response to checkpoint inhibitors (CPIs), whereas there is limited knowledge regarding whether these factors reciprocally impact the treatment outcomes of CPIs in metastatic urothelial carcinoma (mUC). Herein, we investigated treatment outcomes of platinum‐refractory mUC patients (50 cases with whole‐exome and transcriptome sequencing) treated with pembrolizumab. The pathological review identified 24% of cases of TLS in the specimens. There was no significant difference in the NLR between the TLS− and TLS+ groups ( p = 0.153). In the lower NLR group, both overall survival and progression‐free survival were significantly longer in patients with TLS than in those without TLS, whereas the favorable outcomes associated with TLS were not observed in patients in the higher NLR group. We explored transcriptomic differences in UC with TLS. The TLS was comparably observed between luminal (20%) and basal (25%) tumor subtypes ( p = 0.736). Exploring putative immune‐checkpoint genes revealed that ICOSLG (B7‐H2) was significantly increased in tumors with lower NLR. KRT expression levels exhibited higher basal cell markers (KRT5 and KRT17) in the higher NLR group and lower differentiated cell markers (KRT8 and KRT18) in patients with TLS. In conclusion, the improved outcomes of pembrolizumab treatment in mUC are restricted to patients with lower NLR. Our findings begin to elucidate a distinct molecular pattern for the presence of TLS according to the NLR in peripheral blood." @default.
• W4387078052 created "2023-09-28" @default.
• W4387078052 creator A5000723708 @default.
• W4387078052 creator A5002217801 @default.
• W4387078052 creator A5003587912 @default.
• W4387078052 creator A5007413510 @default.
• W4387078052 creator A5010445228 @default.
• W4387078052 creator A5021559677 @default.
• W4387078052 creator A5022236909 @default.
• W4387078052 creator A5024205770 @default.
• W4387078052 creator A5024298648 @default.
• W4387078052 creator A5027019057 @default.
• W4387078052 creator A5029100598 @default.
• W4387078052 creator A5029568633 @default.
• W4387078052 creator A5030580122 @default.
• W4387078052 creator A5030942209 @default.
• W4387078052 creator A5031894721 @default.
• W4387078052 creator A5039665271 @default.
• W4387078052 creator A5041446188 @default.
• W4387078052 creator A5065751906 @default.
• W4387078052 creator A5068891653 @default.
• W4387078052 creator A5071593174 @default.
• W4387078052 creator A5072415868 @default.
• W4387078052 creator A5072987336 @default.
• W4387078052 creator A5077446693 @default.
• W4387078052 creator A5078064024 @default.
• W4387078052 date "2023-09-26" @default.
• W4387078052 modified "2023-10-14" @default.
• W4387078052 title "Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab" @default.
• W4387078052 cites W1834505123 @default.
• W4387078052 cites W1984068087 @default.
• W4387078052 cites W2019607817 @default.
• W4387078052 cites W2067964015 @default.
• W4387078052 cites W2068457469 @default.
• W4387078052 cites W2588916311 @default.
• W4387078052 cites W2592144107 @default.
• W4387078052 cites W2607136978 @default.
• W4387078052 cites W2782546217 @default.
• W4387078052 cites W2943108118 @default.
• W4387078052 cites W2998795792 @default.
• W4387078052 cites W3000311037 @default.
• W4387078052 cites W3087464965 @default.
• W4387078052 cites W3120538773 @default.
• W4387078052 cites W3127371144 @default.
• W4387078052 cites W3178476179 @default.
• W4387078052 cites W3187890850 @default.
• W4387078052 cites W3200255026 @default.
• W4387078052 cites W4200616055 @default.
• W4387078052 cites W4205454312 @default.
• W4387078052 cites W4220741158 @default.
• W4387078052 cites W4295358216 @default.
• W4387078052 doi "https://doi.org/10.1111/cas.15976" @default.
• W4387078052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37752769" @default.
• W4387078052 hasPublicationYear "2023" @default.
• W4387078052 type Work @default.
• W4387078052 citedByCount "0" @default.
• W4387078052 crossrefType "journal-article" @default.
• W4387078052 hasAuthorship W4387078052A5000723708 @default.
• W4387078052 hasAuthorship W4387078052A5002217801 @default.
• W4387078052 hasAuthorship W4387078052A5003587912 @default.
• W4387078052 hasAuthorship W4387078052A5007413510 @default.
• W4387078052 hasAuthorship W4387078052A5010445228 @default.
• W4387078052 hasAuthorship W4387078052A5021559677 @default.
• W4387078052 hasAuthorship W4387078052A5022236909 @default.
• W4387078052 hasAuthorship W4387078052A5024205770 @default.
• W4387078052 hasAuthorship W4387078052A5024298648 @default.
• W4387078052 hasAuthorship W4387078052A5027019057 @default.
• W4387078052 hasAuthorship W4387078052A5029100598 @default.
• W4387078052 hasAuthorship W4387078052A5029568633 @default.
• W4387078052 hasAuthorship W4387078052A5030580122 @default.
• W4387078052 hasAuthorship W4387078052A5030942209 @default.
• W4387078052 hasAuthorship W4387078052A5031894721 @default.
• W4387078052 hasAuthorship W4387078052A5039665271 @default.
• W4387078052 hasAuthorship W4387078052A5041446188 @default.
• W4387078052 hasAuthorship W4387078052A5065751906 @default.
• W4387078052 hasAuthorship W4387078052A5068891653 @default.
• W4387078052 hasAuthorship W4387078052A5071593174 @default.
• W4387078052 hasAuthorship W4387078052A5072415868 @default.
• W4387078052 hasAuthorship W4387078052A5072987336 @default.
• W4387078052 hasAuthorship W4387078052A5077446693 @default.
• W4387078052 hasAuthorship W4387078052A5078064024 @default.
• W4387078052 hasBestOaLocation W43870780521 @default.
• W4387078052 hasConcept C104317684 @default.
• W4387078052 hasConcept C126322002 @default.
• W4387078052 hasConcept C143998085 @default.
• W4387078052 hasConcept C150194340 @default.
• W4387078052 hasConcept C162317418 @default.
• W4387078052 hasConcept C203014093 @default.
• W4387078052 hasConcept C2777701055 @default.
• W4387078052 hasConcept C2777761686 @default.
• W4387078052 hasConcept C2778024521 @default.
• W4387078052 hasConcept C2778326572 @default.
• W4387078052 hasConcept C2778963024 @default.
• W4387078052 hasConcept C2779306644 @default.
• W4387078052 hasConcept C2780057760 @default.
• W4387078052 hasConcept C55493867 @default.
• W4387078052 hasConcept C71924100 @default.
• W4387078052 hasConcept C86803240 @default.
• W4387078052 hasConcept C8891405 @default.
• W4387078052 hasConceptScore W4387078052C104317684 @default.

• next